AVDL
Avadel Pharmaceuticals Plc · HEALTHCARE
Director Mark Anthony Mccamish sold $1.1M of Avadel Pharmaceuticals Plc
Sold$1,089,750
$14.53Price
75,000Shares
−53%Stake
What AVDL did after the filing
- The stock from Fri, Dec 29 close, $14.12
- +0.2%
- S&P 500, same days
- +3.9%
Measured over 30 trading days, to the Feb 13 close.
Traded Thu, Dec 28. Filed Fri, Dec 29, 11:15 AM ET, during the session. Returns use the Dec 29 close and the Feb 13 close. Not investment advice.